We compared immunogenicity and reactogenicity of a single dose of DTaP vaccine
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …

Background. The high reactogenicity of whole cell pertussis vaccines discourages their use
in children. While acellular pertussis vaccines are less reactogenic, their use in diphtheria …

Background Multivalent vaccines containing whole-cell pertussis (wP) antigens combined
with established diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b …

Reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) vaccine, Boostrix™,
is indicated for booster vaccination of children, adolescents and adults. The original prefilled …

BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …

Abstract Introduction TETRAXIM™(Sanofi), a combined diphtheria, tetanus, acellular
pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea …

OBJECTIVE: To evaluate antibody persistence one year after three-dose primary
vaccination and booster immune response during the second year of life for a fully liquid …

Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …

Background Recombinant pertussis vaccines inducing long-lasting immune responses
could help to control the rise in pertussis. We here report on persisting antibody responses 2 …

This study compared the levels of immunogenicity and safety of diphtheria–tetanus toxoid–
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …